C-reactive protein is a bystander of cardiovascular disease
Open Access
- 30 July 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (17), 2092-2096
- https://doi.org/10.1093/eurheartj/ehq242
Abstract
A large number of studies have evaluated the association of hs-C-reactive protein with atherosclerosis and coronary heart disease (CHD) in mechanistic, genetic, population-based studies, as well as clinical trials. This paper reviews the collective evidence to determine if hs-C-reactive protein is part of the causal pathway of atherosclerosis and CHD or whether it is a bystander.Keywords
This publication has 27 references indexed in Scilit:
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2009
- Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic RabbitsCirculation, 2009
- Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhereCurrent Opinion in Lipidology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytesJournal of Leukocyte Biology, 2008
- C-Reactive Protein Inhibits Cholesterol Efflux From Human Macrophage-Derived Foam CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 2004
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003